Benjamin Alt Email & Phone Number

Blainville, Québec, Ca

I am pleased to announce I made a new move to an incredible company called Neopharm Labs. With over 30 years of experience, Neopharm provides a full range of R&D and GMP analytical testing services for small and large molecules. These services include analytical chemistry, isolation services, method development and validation, microbiology, elemental analysis, stability studies, Extractable and Leachable studies, Biomolecule quantitation and Characterization and raw material testing. Additionally, Neopharm specializes in biopharmaceutical services supporting the development, characterization and qualification of cell and gene therapies, including viral vectors and RNA molecules. We have also expertise in cell-based potency assays.Regularly inspected by regulatory bodies like the U.S. FDA and Health Canada, Neopharm supports pharmaceutical, biotechnology, and life sciences companies across North America and globally. We have 3 sites including our headquarters in Blainville as well as offices in Laval and a full range of services offered in our Boston Lab as well.Feel free to message or DM me directly discuss about how we can help.I’m looking forward to working with this wonderful organization!

Ghent, Flemish Region, Be

Laval, Quebec, Ca

Laval, Quebec, Ca

Blainville, Québec, Ca

• Identified, contacted and fostered relationships with Key Opinion Leaders (KOL’s) in the area of Gastroenterology, Gynecology, Hepatology, Hematology and Endocrinology • Provided commercially relevant recommendations, ideas and advice to improve decision making and results, consistent with operational & financial objectives• Gained experience in business analysis and sales forecasting, usage of internal data as well as competitive product and market intelligence data• Liaised with the commercial team in preparation of pre-launch activities for several innovative brands in Urology, Hematology, Oncology & Women’s Health• Assessed, valued and was influential in the due diligence for Osphena, a novel women’s health product that was acquired by Duchesnay from Shionogi to grow the US women’s health business• Led the due diligence process including the evaluation and approval process for several new generic and OTC opportunities, including business case valuation, forecasting and preparing recommendations for Senior Management approval, with knowledge and support of other key internal and external stakeholders• Developed knowledge and competencies in several areas including women’s health, urology, orphan diseases & Life Cycle Management • Fostered relationships with existing partners by negotiating key clauses into agreements such as a right of 1st refusal to leverage new opportunities from partnerships already in place• Acquired understanding of market access complexities, distribution and pricing strategies for both the US & Canadian pharmaceutical markets while working closely with patient support groups and 3rd party consultants • Represented Duchesnay at numerous conferences including DCAT, BIO and others while networking with pharma, biotechs, payers, regulators and patient advocates

Pointe-Claire, Quebec, Ca

• Grew annual sales overall by +10% in 2015 sales by +12% in 2014 • Had highest sales in Canada while covering the south shore region of Quebec in Q4 2015 & Q1 2016 • Sold directly to pharmacy owners in Quebec and Ontario pharmacies• Negotiated contracts across Canada to secure our products in wholesales and major banners such as Shoppers, Sobeys, Walmart, Costco, Kohl & Frisch, Metro & McKesson • Identified, hired, trained and directed a team of 7 sales representatives and had 10 direct reports • Developed marketing plans, branding, CRM, sales tactics and promotional items for OTC/BTC pharmaceutical products•Assumed ownership of key internal brand presentations such as Business Reviews & Sales Meetings/Training•Secured several new large key accounts such as Rexall as Jean Coutu

• Responsible for all Business Development activities for Canada and Northeastern United States including prospecting new leads, capability presentations and proposal negotiations • Member of the investment team for Cato BioVentures, the venture capital affiliate of Cato Research and performed research analysis on potential acquisition of assets and technologies• Closed 5 Business Development deals in the 1st year of employment • Drafted proposals for clients including financial assessments and budgeting

Laval, Quebec, Ca

During my 7 years at Valeant I was involved in helping the company grow from ~$60M revenue to $336M through the execution of over 19 Canadian Business Development agreements such as; in-licensing, Merger & Acquisitions, divestitures and co-promotions. • Initiated, assessed the financial valuation of $3-4M, led due diligence teams and completed the negotiation of a deal to acquire a novel dermatology product for the specialty dermatology business unit • Directed cross-functional Regulatory Affairs and Marketing teams into due diligence which led to the negotiation of a $1.5M deal and closed the transaction within 2 months enabling Valeant to acquire clinical data to support the Canadian regulatory filing of a new indication for one of its key cardiology assets • Led the Valeant Canada Consumer Products (VCCP) division to assess the value of acquiring a $20M company for the consumer business. Tasks in Due Diligence included new regulatory affairs submissions, pricing implications, developing marketing strategies, Quality Control, review of all legal agreements as well as financial modeling and deal valuation.• Screened, identified, evaluated and licensed a new contract manufacturer in order to provide product supply for Valeant to commercialize one of its products, the process from initial identification to deal closure was less than 4 months • Integrated a portfolio of ophthalmic orphan/niche products valued at $5-7M ensuring proper supply chain management, Quality Control, inventory planning, government relations/rebate programs and patient registration in the Special Access Program (SAP)

Laval, Quebec, Ca

• Developed forecasts and financial models to assess the valuation of various in-licensing opportunities such as Ultravate and Onsolis • Assisted in the initial assessment, analysis and due diligence for the acquisition of Laboratoire Dr. Renaud• Designed a list of potential M&A dermatology targets and screened the list for a selected list of targets among which Valeant acquired two of those companies• Drafted a position paper to explain the benefits of in-licensing an opportunity for the treatment of insomnia • Assessed, valued and led a team in negotiations for the in-licensing of a topical analgesic for osteoarthritis • Directed a team of market research consultants to design physician and patient questionnaires• Led a Commercial and Supply team to integrate a portfolio of 7 new products (Rx, OTC and SAP) into the organization within 6 months

Montreal, Quebec, Ca

Report directly to the Executive DirectorResponsible for preparing licensing agreements for the Ministry of Health and Social Services Implemented a methodology to retrieve financial and operational figures for budget reporting

Reported directly to the President/CEOResponsible in identifying in-licensing and out-licensing partnering opportunities which include screening companies by analyzing market strategies, sending confidential data, managing follow-ups, setting up web casts, videoconferences and teleconferences for prospective partnersParticipated in partnering discussions and conducted due diligence sessions with large Pharmaceutical and Biotech companies such as Serono, Amgen and Roche Developed negotiating strategies by studying integration of new projects with internal company strategies and operations; examining risks and potentials; estimating partners' needs and goals.Facilitated new business deals by coordinating requirements; developing and negotiating contracts; researched, benchmarked and applied financial models to draft term sheetsUpdated job knowledge by participating in scientific project update meetings, reading publications; maintaining personal networks; participating in professional organizations

Québec, Québec, Ca

Masters project specialized in the field of Oncology, Molecular Biology, Genetics, Toxicology, Hepatocarcinogenesis and Genomics Research.

Mba, Marketing Specialization

M.Sc., Masters In Experimental Health Medicine (Cancer Research)

B.Sc., Biology